Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Rivory, LP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rivory, LP; Clarke, SJ; Boyer, M; Bishop, JF
      Highly sensitive analysis of the antifolate pemetrexed sodium, a new cancer agent, in human plasma and urine by high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    2. Hoskins, JM; Gross, AS; Shenfield, GM; Rivory, LP
      High-performance liquid chromatography-electrospray ionization mass spectrometry method for the measurement of moclobemide and two metabolites in plasma

      JOURNAL OF CHROMATOGRAPHY B
    3. Ong, SYK; Clarke, SJ; Bishop, J; Dodds, HM; Rivory, LP
      Toxicity of irinotecan (CPT-11) and hepato-renal dysfunction

      ANTI-CANCER DRUGS
    4. Cho, CSL; McLean, AJ; Rivory, LP; Gatenby, PA; Hardman, DTA; Le Couteur, DG
      Carbon monoxide wash-in method to determine gas transfer in vascular beds:application to rat hindlimb

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    5. Rivory, LP; Slaviero, KA; Hoskins, JM; Clarke, SJ
      The erythromycin breath test for the prediction of drug clearance

      CLINICAL PHARMACOKINETICS
    6. Rivory, LP; Watkins, PB
      Erythromycin breath test

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    7. Dodds, HM; Rivory, LP
      Comment on a published paper

      BRITISH JOURNAL OF PHARMACOLOGY
    8. Rivory, LP; Slaviero, K; Seale, JP; Hoskins, JM; Boyer, M; Beale, PJ; Millward, MJ; Bishop, JF; Clarke, SJ
      Optimizing the erythromycin breath test for use in cancer patients

      CLINICAL CANCER RESEARCH
    9. Yang, MC; McLean, AJ; Rivory, LP; Le Couteur, DG
      Hepatic disposition of neurotoxins and pesticides

      PHARMACOLOGY & TOXICOLOGY
    10. Dodds, HM; Clarke, SJ; Findlay, M; Bishop, JF; Robert, J; Rivory, LP
      Clinical pharmacokinetics of the irinotecan metabolite 4-piperidinopiperidine and its possible clinical importance

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    11. Clarke, SJ; Beale, PJ; Rivory, LP
      Clinical and preclinical pharmacokinetics of raltitrexed

      CLINICAL PHARMACOKINETICS
    12. Rivory, LP; Qin, H; Clarke, SJ; Eris, J; Duggin, G; Ray, E; Trent, RJ; Bishop, JF
      Frequency of cytochrome P-450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    13. Clarke, SJ; Rivory, LP
      Clinical pharmacokinetics of docetaxel

      CLINICAL PHARMACOKINETICS
    14. Le Couteur, DG; Yin, ZL; Rivory, LP; McLean, AJ
      Carbon monoxide disposition in the perfused rat liver

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    15. Dodds, HM; Rivory, LP
      The mechanism for the inhibition of acetylcholinesterases by irinotecan (CPT-11)

      MOLECULAR PHARMACOLOGY
    16. Dodds, HM; Bishop, JF; Rivory, LP
      More about: Irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatin

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    17. RIVORY LP; FINDLAY M; CLARKE S; BISHOP J
      TRACE ANALYSIS OF SN-38 IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of chromatography B. Biomedical sciences and applications
    18. HAAZ MC; DODDS HM; RIOU JF; RICHE C; RIVORY LP; ROBERT J
      IDENTIFICATION OF A NEW METABOLITE OF CPT-11 (IRINOTECAN) - BIOSYNTHESIS AND ACTIVATION TO SN-38 BY HUMAN HEPATIC MICROSOMES

      Annals of oncology
    19. RIVORY LP; CLARKE S; BISHOP JF; ODONNELL A; EMMETT L; FINDLAY M
      IRINOTECAN (CPT-11) - A PRELIMINARY INVESTIGATION OF THE RELATIONSHIPBETWEEN TROUGH CONCENTRATIONS OF THE ACTIVE METABOLITE, SN-38, AND TOXICITY

      Annals of oncology
    20. DODDS HM; ROBERT J; RIVORY LP
      THE DETECTION OF PHOTODEGRADATION PRODUCTS OF IRINOTECAN (CPT-11, CAMPTO(R), CAMPTOSAR(R)), IN CLINICAL-STUDIES, USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ATMOSPHERIC-PRESSURE CHEMICAL-IONIZATION MASS-SPECTROMETRY

      Journal of pharmaceutical and biomedical analysis
    21. HAAZ MC; RICHE C; RIVORY LP; ROBERT J
      BIOSYNTHESIS OF AN AMINOPIPERIDINO METABOLITE OF IRINOTECAN PIPERIDINO)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECINE] BY HUMAN HEPATIC MICROSOMES

      Drug metabolism and disposition
    22. DODDS HM; HAAZ MC; RIOU JF; ROBERT J; RIVORY LP
      IDENTIFICATION OF A NEW METABOLITE OF CPT-11 (IRINOTECAN) - PHARMACOLOGICAL PROPERTIES AND ACTIVATION TO SN-38

      The Journal of pharmacology and experimental therapeutics
    23. RIVORY LP; HAAZ MC; CANAL P; LOKIEC F; ARMAND JP; ROBERT J
      PHARMACOKINETIC INTERRELATIONSHIPS OF IRINOTECAN (CPT-11) AND ITS 3 MAJOR PLASMA METABOLITES IN PATIENTS ENROLLED IN PHASE-I II TRIALS/

      Clinical cancer research
    24. ROBERTS MS; WU ZY; RIVORY LP; SMITHERS BM; EGERTON WS; WEISS M
      RELATIVE DISPERSION OF INTRAVASCULAR TRANSIT TIMES DURING ISOLATED HUMAN LIMB PERFUSIONS FOR RECURRENT MELANOMA

      British journal of clinical pharmacology
    25. HAAZ MC; RIVORY LP; RICHE C; ROBERT J
      THE TRANSFORMATION OF IRINOTECAN (CPT-11) TO ITS ACTIVE METABOLITE SN-38 BY HUMAN LIVER-MICROSOMES - DIFFERENTIAL HYDROLYSIS FOR THE LACTONE AND CARBOXYLATE FORMS

      Naunyn-Schmiedeberg's archives of pharmacology
    26. DODDS HM; CRAIK DJ; RIVORY LP
      PHOTODEGRADATION OF IRINOTECAN (CPT-11) IN AQUEOUS-SOLUTIONS - IDENTIFICATION OF FLUORESCENT PRODUCTS AND INFLUENCE OF SOLUTION COMPOSITION

      Journal of pharmaceutical sciences
    27. LECOUTEUR DG; RIVORY LP; POND SM
      THE EFFECT OF OXIDATIVE INJURY ON HEPATOCELLULAR INFLUX OF LEUCINE INTHE RAT

      HEPATOLOGY RESEARCH
    28. RIVORY LP; AVENT KM; POND SM
      EFFECTS OF LIPOPHILICITY AND PROTEIN-BINDING ON THE HEPATOCELLULAR UPTAKE AND HEPATIC DISPOSITION OF 2 ANTHRACYCLINES, DOXORUBICIN AND IODODOXORUBICIN

      Cancer chemotherapy and pharmacology
    29. RIVORY LP
      IRINOTECAN (CPT-11) - A BRIEF OVERVIEW

      Clinical and experimental pharmacology and physiology
    30. DODDS HM; WALPOLE ET; RIVORY LP; STRONG RW; POND SM
      DISPOSITION OF EPIRUBICIN AFTER INTRAARTERIAL ADMINISTRATION IN LIPIODOL TO PATIENTS WITH HEPATOCELLULAR-CARCINOMA

      Therapeutic drug monitoring
    31. BOURZAT JD; VUILHORGNE M; RIVORY LP; ROBERT J; COMMERCON A
      SEMISYNTHESIS OF RPR 121056A, A MAJOR METABOLITE OF IRINOTECAN (CPT-11)

      Tetrahedron letters
    32. RIVORY LP; RIOU JF; HAAZ MC; SABLE S; VUILHORGNE M; COMMERCON A; POND SM; ROBERT J
      IDENTIFICATION AND PROPERTIES OF A MAJOR PLASMA METABOLITE OF IRINOTECAN (CPT-11) ISOLATED FROM THE PLASMA OF PATIENTS

      Cancer research
    33. RIVORY LP; BOWLES MR; ROBERT J; POND SM
      CONVERSION OF IRINOTECAN (CPT-11) TO ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN (SN-38), BY HUMAN LIVER CARBOXYLESTERASE

      Biochemical pharmacology
    34. LECOUTEUR D; RIVORY LP; YI C; POND SM
      AGING, ACUTE OXIDATIVE INJURY AND HEPATOCELLULAR GLUCOSE-TRANSPORT INTHE RAT

      HEPATOLOGY RESEARCH
    35. RIVORY LP; CANAL P; MATHIEUBOUE A; ROBERT J
      PHARMACOKINETICS AND INTERCONVERSION OF THE CARBOXYLATE AND LACTONE FORMS OF IRINOTECAN (CPT-11) AND OF ITS METABOLITE SN-38 IN PATIENTS

      European journal of cancer
    36. RIVORY LP; ROBERT J
      IDENTIFICATION AND KINETICS OF A BETA-GLUCURONIDE METABOLITE OF SN-38IN HUMAN PLASMA AFTER ADMINISTRATION OF THE CAMPTOTHECIN DERIVATIVE IRINOTECAN

      Cancer chemotherapy and pharmacology
    37. RIVORY LP; ROBERT J
      MOLECULAR, CELLULAR, AND CLINICAL ASPECTS OF THE PHARMACOLOGY OF 20(S)CAMPTOTHECIN AND ITS DERIVATIVES

      Pharmacology & therapeutics
    38. RIVORY LP; ROBERT J
      PHARMACOLOGY OF CAMPTOTHECIN AND ITS DERI VATIVES

      Bulletin du cancer
    39. RIVORY LP; ROBERT J
      REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THESIMULTANEOUS QUANTITATION OF THE CARBOXYLATE AND LACTONE FORMS OF THECAMPTOTHECIN DERIVATIVE IRINOTECAN, CPT-11, AND ITS METABOLITE SN-38 IN PLASMA

      Journal of chromatography B. Biomedical applications
    40. LECOUTEUR DG; RIVORY LP; POND SM
      GLUCOSE-TRANSPORT AND HYPOXIA-REOXYGENATION INJURY IN THE PERFUSED-RAT-LIVER

      Journal of gastroenterology and hepatology
    41. LECOUTEUR DG; RIVORY LP; POND SM
      THE EFFECTS OF AGING AND NUTRITIONAL STATE ON HYPOXIA-REOXYGENATION INJURY IN THE PERFUSED-RAT-LIVER

      Transplantation
    42. RIVORY LP; CHATELUT E; CANAL P; MATHIEUBOUE A; ROBERT J
      KINETICS OF THE IN-VIVO INTERCONVERSION OF THE CARBOXYLATE AND LACTONE FORMS OF IRINOTECAN (CPT-11) AND OF ITS METABOLITE SN-38 IN PATIENTS

      Cancer research
    43. POND SM; RIVORY LP; HAMPSON ECGM; ROBERTS MS
      KINETICS OF TOXIC DOSES OF PARAQUAT AND THE EFFECTS OF HEMOPERFUSION IN THE DOG

      Journal of toxicology. Clinical toxicology
    44. WU ZY; RIVORY LP; ROBERTS MS
      PHYSIOLOGICAL PHARMACOKINETICS OF SOLUTES IN THE ISOLATED-PERFUSED RAT HINDLIMB - CHARACTERIZATION OF THE PHYSIOLOGY WITH CHANGING PERFUSATE FLOW, PROTEIN-CONTENT, AND TEMPERATURE USING STATISTICAL MOMENT ANALYSIS

      Journal of pharmacokinetics and biopharmaceutics
    45. LECOUTEUR DG; RIVORY LP; POND SM
      HEPATIC INTRACELLULAR PH DURING THE PREREPLICATIVE PERIOD FOLLOWING PARTIAL-HEPATECTOMY

      The American journal of physiology
    46. RIVORY LP; ROBERTS MS; POND SM
      AXIAL TISSUE DIFFUSION CAN ACCOUNT FOR THE DISPARITY BETWEEN CURRENT MODELS OF HEPATIC ELIMINATION FOR LIPOPHILIC DRUGS

      Journal of pharmacokinetics and biopharmaceutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 02:55:09